Insider buying last 90 days
No open-market insider purchases were filed for KVUE in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every KVUE insider filing, plotted on the chart in Gekko.Open KVUE in Gekko
NYSE: KVUE
Kenvue (KVUE) Stock Analysis & Forecast
Oct 30 close
$19.31−0.25 (−1.3%)
Gekko Brief
AI summaryOct 30 closeKenvue's week is dominated by Kimberly-Clark's completed acquisition of the company, a deal valued at $49 billion that brings together Tylenol, Neutrogena, Listerine and other brands across 10 billion-dollar franchises. Kimberly-Clark expects $2.1 billion in run-rate synergies, including $1.9 billion in cost reductions. Related filings mark the formal close of the transaction, including the expiration of exchange offers for Kenvue notes, with consent participation ranging from 73.93% to 98.54% across note series, and registration statement amendments deregistering Kenvue's prior securities.
Shares closed at $19.31, down 1.3% on the day, sitting above both the 50-day average of $18.41 and the 200-day average of $18.19. The one-month return stands at 12.1% and the one-year return at 34.9%. The GekkoIndex reads 49, placing the stock in the Neutral zone, up 2.9 over five days. Gekko Fair Value is set at $22.86, leaving price 15.5% below that level.
The next earnings date is listed as 16 February 2027, 103 days away, outside a typical 20-trading-day holding window; the most recent report on 30 October 2026 showed EPS of $0.29 against a $0.29 estimate, with 5 beats across the last 8 quarters. No insider, Congress, or unusual options activity appears in the current window. Seasonally, the next 20 trading days have averaged a 4.9% gain across 3 years, positive in all 3. Analyst coverage from 7 firms shows 1 buy and 6 hold ratings, with a consensus target of $19.50.
Written by AI from the Oct 30, 2026 close and checked automatically against the figures on this page.
Kenvue price vs fair value
Close $19.31200-day averageGekko Fair Value $22.86
Kenvue quick facts
- Market cap
- $37.09B
- P/E ratio
- 21.9
- Forward P/E
- 16.1
- EPS, TTM
- $0.88
- Revenue, TTM
- $15.53B
- Profit margin
- 10.9%
- Dividend yield
- 4.26%
- Beta
- 0.40
- Volume
- 66.60M avg 20.70M
- 1-year return
- +34.9%
- Typical daily move
- ±2.2%
- Typical 20-day move
- ±5.2%
- 50-day average
- $18.41
- 200-day average
- $18.19
- Next earnings
- Feb 16 before open
- Shares outstanding
- 1.92B
Kenvue swing-trade checklist
Kenvue scores 4 supportive, 1 mixed and 0 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
4 supportive1 mixed0 headwinds
- Trendsupportive
Above 50 and 200-day
Close $19.31 is above the 50-day ($18.41) and 200-day ($18.19) averages, and the 50-day is above the 200-day.
See the chart - GekkoIndexmixed
49, Neutral
Reading 49 is in the Neutral zone.
See the GekkoIndex - Fair valuesupportive
15.5% below
Price is 15.5% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings risksupportive
Reports in 103 days
Next report Feb 16, 2027, 103 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalitysupportive
+4.9% on average
From this point in the calendar, the next 20 trading days averaged +4.9% over 3 years, rising in 3 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Kenvue stock chart and price history
Kenvue closed at $19.31 on Oct 30, 2026, +34.9% over the past year, inside a 52-week range of $14.02 to $20.13.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- +12.1%
- 3 months
- +1.6%
- 6 months
- +10.8%
- 1 year
- +34.9%
The full KVUE chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open KVUE in Gekko
Follow Kenvue through every session
Put KVUE on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track KVUE in GekkoFree for 7 days. No credit card required.
About Kenvue
Kenvue sells everyday health and personal-care items to households, built around familiar name brands. Shoppers know it for pain relievers, allergy and cold remedies, skin creams, oral-care items and baby products rather than for a single flagship line.
The business is split into three groups. One line handles common ailments such as colds, allergies, pain and digestion, using brands like Tylenol, Nicorette and Zyrtec. Another focuses on skin, hair and sun care through names such as Neutrogena, Aveeno and OGX. A third covers teeth cleaning, baby care, feminine products and wound treatment, marketed as Listerine, Johnson's, Band-Aid and Stayfree.
Kenvue traces its start to 2022 and runs its main offices out of Skillman, New Jersey. It sits under Johnson & Johnson as a subsidiary. Trading of its stock takes place on the NYSE under the ticker KVUE.
- Listed
- NYSE
- Sector
- Consumer non-durables
- Industry
- Household/Personal care
- Website
- kenvue.com
Kenvue GekkoIndex: the smart money zone
Kenvue’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 49, in the Neutral zone, up 2.9 points over five sessions.
49Neutral
Up 2.9 points over five sessions.
Reading for Oct 30, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 38 | −0.6% | −2.8% | ||
| Accumulation | 260 | −0.1% | +1.4% | ||
| Neutral (current zone) | 358 | +0.1% | −0.5% | ||
| Distribution | 40 | +0.7% | −1.2% | ||
| Selling | 1 | Too few readings yet | |||
Average KVUE share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.0% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
See every daily GekkoIndex reading plotted over the KVUE price, zone by zone.Track KVUE in Gekko
Is Kenvue stock overvalued? Gekko Fair Value
Kenvue trades 15.5% below Gekko Fair Value of $22.86, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Kenvue shares are worth, recalculated every trading day.
$22.86
Gekko Fair Value, Nov 4, 2026
15.5% Undervalued
At the end of Aug 2026 the price was 22.2% below the estimate.
Gekko Fair ValueShare price, month end
Gekko Fair Value on every chart, with the gap to price updating daily.Open KVUE in Gekko
Kenvue insider and Congress trading
No open-market insider purchases were filed for Kenvue, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in KVUE were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for KVUE, plotted on the chart in Gekko.Open KVUE in Gekko
Buybacks
Kenvue has been buying back its own shares.
- Bought back, quarter ended Sep 28, 2025
- $70.00M
- As a share of market cap
- 0.19%
- Trailing four quarters
- $318.0M
From company filings.
Hedge funds and billionaires quarter ended Jun 30
0of the funds Gekko tracks hold KVUE.
0added0opened0trimmed2sold out
Which funds are on each side, name by name.Unlock in Gekko
Kenvue earnings: next date and track record
Kenvue reports on Feb 16, 2027, before the open (103 days away), and beat the EPS estimate in 5 of its last 8 reports.
Next earnings report
Feb 16, 2027
Expected before the open, 103 days away
- EPS estimate
- $0.28
- Revenue estimate
- $3.89B
5 of 8reports beat the EPS estimate
±3.4%average move across the report
3 of 7reports followed by a gain
Share-price move across each report
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Oct 30, 2026 | $0.29 est $0.29 | $3.89B est $3.86B | — |
| Aug 6, 2026 | $0.31 est $0.32 | $3.96B est $3.97B | −2.2% |
| May 7, 2026 | $0.32 est $0.26 | $3.91B est $3.84B | −0.5% |
| Feb 17, 2026 | $0.27 est $0.22 | $3.78B est $3.69B | +1.0% |
| Nov 3, 2025 | $0.28 est $0.26 | $3.76B est $3.82B | +11.1% |
| Aug 7, 2025 | $0.29 est $0.28 | $3.84B est $3.85B | −0.5% |
| May 8, 2025 | $0.24 est $0.23 | $3.74B est $3.68B | +5.8% |
| Feb 6, 2025 | $0.26 est $0.26 | $3.66B est $3.76B | −2.7% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Kenvue stock forecast and analyst price targets
Analysts’ average 12-month price target for Kenvue is $19.50, +1.0% from the last close, from 7 firms rating the stock in the last 90 days.
$19.50consensus 12-month target, +1.0% from the last close
Now $19.31Avg $19.50
Low $19High $20
Each firm’s latest rating in the last 90 days: 7 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 15 | UBS | $19 | −1.6% |
| Oct 14 | Citi | $19 | −1.6% |
| Sep 16 | Canaccord Genuity | — | — |
| Sep 14 | Argus Research | — | — |
| Aug 11 | UBS | $19 | −1.6% |
−0.5%average 20-day move after past Neutral readings
+4.9%average move over the next 20 trading days in the last 3 years
±2.2%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Kenvue seasonality: the next 20 trading days
Over the next 20 trading days from Nov 4, Kenvue averaged +4.9% across the last 3 years, rising in 3 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +2.3% | 2 of 3 |
| Next 10 trading days | +2.1% | 3 of 3 |
| Next 15 trading days | +5.3% | 3 of 3 |
| Next 20 trading days | +4.9% | 3 of 3 |
| Next 30 trading days | +4.1% | 2 of 3 |
For scale, KVUE’s typical 20-trading-day move in either direction is about 5.2%.
Kenvue market cap and key statistics
Kenvue’s market cap is $37.09B, with a P/E ratio of 21.9 and revenue of $15.53B over the last twelve months.
Valuation
- Market cap
- $37.09B
- P/E ratio
- 21.9
- Forward P/E
- 16.1
- EPS, TTM
- $0.88
- Gekko Fair Value
- $22.86
Trading
- Volume
- 66.60M
- Avg volume, 20 days
- 20.70M
- 52-week high
- $20.13
- 52-week low
- $14.02
- Shares outstanding
- 1.92B
Financials
- Revenue, TTM
- $15.53B
- Profit margin
- 10.9%
- Return on equity
- 16.3%
- Quarterly earnings growth, YoY
- +6.0%
Risk and income
- Beta
- 0.40
- Typical daily move
- ±2.2%
- Typical 20-day move
- ±5.2%
- Dividend yield
- 4.26%
Kenvue stock news this week
Coverage of Kenvue this week reads neutral: 7 positive, 10 neutral and 5 negative headlines.
- Kenvue deal brings Kimberly Clark (KMB) CEO Michael D. Hsu 10 shares.Stock Titan, Nov 3
- Can Kimberly-Clark's Kenvue Acquisition Unlock Long-Term Growth?TradingView, Nov 3
- Kimberly-Clark Corporation Announces Expiration and Final Results of Exchange Offers for Kenvue NotesStock Titan, Nov 3
- Kimberly-Clark completes acquisition of KenvuePULPAPERnews.com, Nov 3
- Form POS AM Kenvue Inc.StreetInsider, Nov 3
- Kimberly-Clark Acquires Kenvue. Here's What Investors Need to Know Ahead of Its Nov. 5 Earnings Report.The Motley Fool, Nov 3
Kenvue peers
Kenvue’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| PGProcter & Gamble | Neutral | 11.0% below |
| CLColgate-Palmolive | Neutral | 11.8% below |
| ELEstee Lauder Companies | Neutral | 17.4% above |
| KMBKimberly-Clark | Neutral | 10.8% below |
| CHDChurch & Dwight | Neutral | 4.6% above |
| CLXClorox | Distribution | 37.3% below |
A peer links to its own page where one exists.
Kenvue stock FAQ
What is Kenvue’s market cap?
Kenvue’s market cap is $37.09B at the Oct 30, 2026 close of $19.31, with 1.92B shares outstanding. The shares trade on a P/E ratio of 21.9.
What is the Kenvue stock forecast?
The consensus analyst 12-month price target for Kenvue is $19.50, +1.0% from the last close. Of the 7 firms that rated the stock in the last 90 days, 1 rate it a buy, 6 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Kenvue stock overvalued or undervalued?
On Gekko’s estimate Kenvue is undervalued: the Oct 30, 2026 close of $19.31 is 15.5% below Gekko Fair Value of $22.86. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Kenvue report earnings next?
Kenvue is expected to report on Feb 16, 2027, before the market opens (103 days away). Analysts expect earnings of $0.28 per share on revenue of $3.89B. Kenvue beat the earnings estimate in 5 of its last 8 reports, moving 3.4% on average across the report.
What is Kenvue’s 52-week high and low?
Kenvue’s 52-week high is $20.13 and its 52-week low is $14.02; it closed at $19.31 on Oct 30, 2026, +34.9% over the past year. Over the last five years the shares peaked at $27.80 on May 15, 2023.
Is Kenvue stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 5 items with data read as supportive (trend, fair value, earnings risk and seasonality), 1 as mixed (gekkoindex). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Kenvue the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,461 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.